Generation Bio Analyst Ratings
Generation Bio Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
11/10/2023 | 700% | Wedbush | $11 → $9 | Maintains | Outperform |
10/23/2023 | — | JMP Securities | Downgrades | Market Outperform → Market Perform | |
10/19/2023 | — | TD Cowen | Downgrades | Outperform → Market Perform | |
08/16/2023 | 700% | JP Morgan | $8 → $9 | Maintains | Neutral |
08/03/2023 | 1144.44% | Needham | → $14 | Reiterates | → Buy |
08/03/2023 | 877.78% | Wedbush | → $11 | Reiterates | Outperform → Outperform |
05/11/2023 | 1144.44% | Needham | → $14 | Reiterates | Buy → Buy |
04/19/2023 | 1144.44% | Needham | → $14 | Reiterates | → Buy |
03/24/2023 | 522.22% | JMP Securities | → $7 | Reiterates | → Market Outperform |
03/23/2023 | 1144.44% | Needham | → $14 | Reiterates | → Buy |
03/06/2023 | 98.22% | JMP Securities | $7 → $2.23 | Maintains | Market Outperform |
02/24/2023 | 1233.33% | Wedbush | $24 → $15 | Maintains | Outperform |
02/24/2023 | 1144.44% | Needham | $23 → $14 | Maintains | Buy |
01/19/2023 | 522.22% | JMP Securities | $11 → $7 | Maintains | Market Outperform |
11/08/2022 | 700% | Canaccord Genuity | → $9 | Initiates Coverage On | → Buy |
08/08/2022 | 877.78% | JMP Securities | $10 → $11 | Maintains | Market Outperform |
08/05/2022 | 1944.44% | Needham | $27 → $23 | Maintains | Buy |
12/15/2021 | 788.89% | JMP Securities | $40 → $10 | Maintains | Market Outperform |
12/15/2021 | 2300% | Needham | $50 → $27 | Maintains | Buy |
12/14/2021 | 2655.56% | Wedbush | $36 → $31 | Maintains | Outperform |
07/14/2021 | 3100% | Wedbush | $40 → $36 | Maintains | Outperform |
06/08/2021 | 3455.56% | JMP Securities | → $40 | Initiates Coverage On | → Market Outperform |
02/24/2021 | 3900% | William Blair | → $45 | Initiates Coverage On | → Outperform |
02/18/2021 | 4344.44% | Needham | → $50 | Initiates Coverage On | → Buy |
07/07/2020 | 2655.56% | Wedbush | → $31 | Initiates Coverage On | → Outperform |
07/07/2020 | — | Cowen & Co. | Initiates Coverage On | → Outperform | |
07/07/2020 | 2388.89% | JP Morgan | → $28 | Initiates Coverage On | → Overweight |
07/07/2020 | 3277.78% | Jefferies | → $38 | Initiates Coverage On | → Buy |
日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
---|---|---|---|---|---|
11/10/2023 | 700% | Wedbush | 11 美元 → 9 美元 | 維護 | 跑贏大盤 |
2023 年 10 月 23 日 | — | JMP 證券 | 降級 | 市場跑贏大盤 → 市場表現 | |
2023 年 10 月 19 日 | — | TD Cowen | 降級 | 跑贏大盤 → 市場表現 | |
08/16/2023 | 700% | 摩根大通 | 8 美元 → 9 美元 | 維護 | 中立 |
08/03/2023 | 1144.44% | 尼德姆 | → 14 美元 | 重申 | → 購買 |
08/03/2023 | 877.78% | Wedbush | → 11 美元 | 重申 | 跑贏大盤 → 跑贏大盤 |
05/11/2023 | 1144.44% | 尼德姆 | → 14 美元 | 重申 | 購買 → 購買 |
04/19/2023 | 1144.44% | 尼德姆 | → 14 美元 | 重申 | → 購買 |
2023 年 3 月 24 日 | 522.22% | JMP 證券 | → 7 美元 | 重申 | → 市場跑贏大盤 |
03/23/2023 | 1144.44% | 尼德姆 | → 14 美元 | 重申 | → 購買 |
03/06/2023 | 98.22% | JMP 證券 | 7 美元 → 2.23 美元 | 維護 | 市場表現跑贏大盤 |
02/24/2023 | 1233.33% | Wedbush | 24 美元 → 15 美元 | 維護 | 跑贏大盤 |
02/24/2023 | 1144.44% | 尼德姆 | 23 美元 → 14 美元 | 維護 | 買 |
01/19/2023 | 522.22% | JMP 證券 | 11 美元 → 7 美元 | 維護 | 市場表現跑贏大盤 |
2022 年 8 月 11 日 | 700% | Canaccord Genu | → 9 美元 | 啓動覆蓋範圍開啓 | → 購買 |
08/08/2022 | 877.78% | JMP 證券 | 10 美元 → 11 美元 | 維護 | 市場表現跑贏大盤 |
08/05/2022 | 1944.44% | 尼德姆 | 27 美元 → 23 美元 | 維護 | 買 |
2021 年 12 月 15 日 | 788.89% | JMP 證券 | 40 美元 → 10 美元 | 維護 | 市場表現跑贏大盤 |
2021 年 12 月 15 日 | 2300% | 尼德姆 | 50 美元 → 27 美元 | 維護 | 買 |
12/14/2021 | 2655.56% | Wedbush | 36 美元 → 31 美元 | 維護 | 跑贏大盤 |
2021 年 7 月 14 日 | 3100% | Wedbush | 40 美元 → 36 美元 | 維護 | 跑贏大盤 |
06/08/2021 | 3455.56% | JMP 證券 | → 40 美元 | 啓動覆蓋範圍開啓 | → 市場跑贏大盤 |
2021 年 2 月 24 日 | 3900% | 威廉布萊爾 | → 45 美元 | 啓動覆蓋範圍開啓 | → 跑贏大盤 |
2021 年 2 月 18 日 | 4344.44% | 尼德姆 | → 50 美元 | 啓動覆蓋範圍開啓 | → 購買 |
07/07/2020 | 2655.56% | Wedbush | → 31 美元 | 啓動覆蓋範圍開啓 | → 跑贏大盤 |
07/07/2020 | — | Cowen & Co. | 啓動覆蓋範圍開啓 | → 跑贏大盤 | |
07/07/2020 | 2388.89% | 摩根大通 | → 28 美元 | 啓動覆蓋範圍開啓 | → 超重 |
07/07/2020 | 3277.78% | 傑富瑞集團 | → 38 美元 | 啓動覆蓋範圍開啓 | → 購買 |
What is the target price for Generation Bio (GBIO)?
Generation Bio(GBIO)的目標價格是多少?
The latest price target for Generation Bio (NASDAQ: GBIO) was reported by Wedbush on November 10, 2023. The analyst firm set a price target for $9.00 expecting GBIO to rise to within 12 months (a possible 700.00% upside). 14 analyst firms have reported ratings in the last year.
Wedbush於2023年11月10日公佈了Generation Bio(納斯達克股票代碼:GBIO)的最新目標股價。該分析公司將目標股價定爲9.00美元,預計GBIO將在12個月內升至12個月內(可能上漲700.00%)。去年有14家分析公司公佈了評級。
What is the most recent analyst rating for Generation Bio (GBIO)?
分析師對Generation Bio(GBIO)的最新評級是多少?
The latest analyst rating for Generation Bio (NASDAQ: GBIO) was provided by Wedbush, and Generation Bio maintained their outperform rating.
Wedbush提供了Generation Bio(納斯達克股票代碼:GBIO)的最新分析師評級,Generation Bio維持了跑贏大盤的評級。
When is the next analyst rating going to be posted or updated for Generation Bio (GBIO)?
Generation Bio(GBIO)的下一次分析師評級何時發佈或更新?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Generation Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Generation Bio was filed on November 10, 2023 so you should expect the next rating to be made available sometime around November 10, 2024.
分析師在進行了廣泛的研究後得出了股票評級,其中包括瀏覽公開財務報表,與Generation Bio的高管和客戶交談,以及聽取業績電話會議。大多數分析師每三個月做一次這樣的評級,因此每家公司每年應該獲得4次評級。Generation Bio的最新評級是在2023年11月10日發佈的,因此您應該預計下一個評級將在2024年11月10日左右公佈。
Is the Analyst Rating Generation Bio (GBIO) correct?
分析師評級一代簡歷(GBIO)是否正確?
While ratings are subjective and will change, the latest Generation Bio (GBIO) rating was a maintained with a price target of $11.00 to $9.00. The current price Generation Bio (GBIO) is trading at is $1.13, which is out of the analyst's predicted range.
儘管評級是主觀的,並且會發生變化,但最新的Generation Bio(GBIO)評級維持不變,目標股價爲11.00美元至9.00美元。Generation Bio(GBIO)目前的交易價格爲1.13美元,超出了分析師的預期區間。